Tinea (Dermatophytosis - Trichophyton, Microsporum, Epidermophyton spp.)
Overview
Plain-Language Overview
Tinea, also known as dermatophytosis, is a common fungal infection that affects the skin, hair, and nails. It is caused by fungi called dermatophytes, which include species from the genera Trichophyton, Microsporum, and Epidermophyton. These fungi thrive on keratin, a protein found in the outer layer of the skin, leading to itchy, red, scaly patches that can be uncomfortable and sometimes painful. The infection can appear in various body areas, such as the feet (athlete’s foot), groin (jock itch), scalp, or body. It spreads easily through direct contact with infected people, animals, or contaminated objects. While not life-threatening, tinea can significantly affect quality of life due to its symptoms and contagious nature.
Clinical Definition
Tinea (dermatophytosis) is a superficial fungal infection caused by keratinophilic dermatophytes, primarily species of Trichophyton, Microsporum, and Epidermophyton. These fungi invade the stratum corneum of the epidermis, hair shafts, and nails, leading to characteristic erythematous, scaly plaques with central clearing and peripheral active borders. The infection is transmitted via direct contact with infected humans, animals, or fomites. Clinically, tinea presents with localized or widespread lesions depending on the site and host immune response. It is significant due to its high prevalence, potential for chronicity, and secondary bacterial infections. Diagnosis relies on clinical features supported by laboratory confirmation. Untreated infections can cause persistent discomfort and cosmetic concerns.
Inciting Event
Direct contact with infected skin, hair, or fomites initiates infection.
Exposure to contaminated soil or animals harboring dermatophytes can trigger infection.
Microtrauma or skin barrier disruption facilitates fungal entry.
Use of shared towels, clothing, or footwear can transmit spores.
Excessive sweating or moisture accumulation creates a favorable environment for fungal growth.
Latency Period
Symptoms typically develop within 1 to 2 weeks after exposure to infectious spores.
Incubation can vary from several days to weeks depending on fungal load and host immunity.
Chronic infections may persist for months without treatment due to slow fungal growth.
Initial asymptomatic colonization may delay symptom onset.
Latency is shorter in immunocompromised hosts due to rapid fungal proliferation.
Diagnostic Delay
Early lesions may be mistaken for eczema or psoriasis due to nonspecific scaling and erythema.
Patients often self-treat with topical corticosteroids, which can mask symptoms and worsen infection.
Lack of awareness about fungal infections leads to delayed medical evaluation.
Misdiagnosis as bacterial cellulitis or allergic dermatitis can delay appropriate antifungal therapy.
Subtle or atypical presentations in immunocompromised patients complicate diagnosis.
Clinical Presentation
Signs & Symptoms
Pruritic, annular, scaly plaques with central clearing and raised borders are hallmark symptoms.
Scaling, fissuring, and maceration commonly affect interdigital spaces in tinea pedis.
Hair loss with broken hairs and scalp scaling occurs in tinea capitis.
Nail thickening and discoloration are typical in onychomycosis.
Mild erythema and inflammation often accompany lesions.
History of Present Illness
Patients report pruritic, scaly, annular plaques with central clearing and raised borders.
Lesions often begin as small, red, scaly patches that expand centrifugally over days to weeks.
Symptoms include itching, burning, and sometimes mild pain at the affected site.
Chronic untreated lesions may develop hyperpigmentation or lichenification.
Involvement of nails (onychomycosis) presents with thickened, discolored, and brittle nails.
Past Medical History
History of previous dermatophyte infections increases risk of recurrence.
Use of immunosuppressive medications or presence of immunodeficiency disorders predisposes to severe disease.
Chronic conditions causing excessive sweating such as diabetes mellitus may contribute.
Prior topical corticosteroid use on affected areas can exacerbate infection.
History of athlete’s foot or tinea pedis is common in patients with tinea corporis or cruris.
Family History
Family members often share similar fungal infections due to close contact and shared environments.
No known genetic predisposition or heritable syndromes are associated with dermatophytosis.
Household clustering is common due to fomite transmission and direct skin contact.
Family history of atopic dermatitis may complicate clinical presentation but is not causative.
Awareness of infected household contacts aids in diagnosis and prevention.
Physical Exam Findings
Annular, scaly plaques with central clearing and an advancing, raised border are characteristic of tinea corporis.
Erythematous, scaly patches with possible vesicles or pustules are common in tinea pedis.
Thickened, discolored, and brittle nails indicate onychomycosis caused by dermatophytes.
Hair shaft invasion with broken hairs and black dots is seen in tinea capitis.
Pruritus and mild erythema are frequent findings in affected skin areas.
Diagnostic Workup
Diagnostic Criteria
Diagnosis of tinea is established by clinical examination revealing annular, scaly plaques with central clearing and active borders. Confirmation requires microscopic identification of septate hyphae in skin scrapings using potassium hydroxide (KOH) preparation. Fungal culture on Sabouraud agar can identify the specific dermatophyte species. Wood’s lamp examination may aid diagnosis in some Microsporum infections by showing fluorescence. Histopathology is rarely needed but shows fungal elements in the stratum corneum.
Pathophysiology
Key Mechanisms
Keratinophilic dermatophytes such as Trichophyton, Microsporum, and Epidermophyton invade and digest keratinized tissues including skin, hair, and nails.
Fungal hyphae proliferate within the stratum corneum, triggering a host inflammatory response that causes erythema and scaling.
Enzymatic degradation of keratin by fungal keratinases facilitates tissue invasion and persistence.
The infection remains superficial due to the fungi's inability to invade living deeper tissues or elicit systemic immune responses.
Delayed-type hypersensitivity reactions contribute to the characteristic pruritus and inflammation.
| Involvement | Details |
|---|---|
| Organs | Skin is the primary organ affected by tinea, showing characteristic scaling and inflammation. |
Nails can be involved in onychomycosis, a chronic fungal infection of the nail plate. | |
| Tissues | Stratum corneum is the outermost skin layer where dermatophytes colonize and degrade keratin. |
Epidermis provides the barrier and immune environment involved in fungal defense. | |
| Cells | Keratinocytes serve as the primary site of fungal invasion and produce antimicrobial peptides in response. |
Langerhans cells present fungal antigens to initiate adaptive immune responses. | |
Neutrophils infiltrate infected tissue to phagocytose fungi and release reactive oxygen species. | |
| Chemical Mediators | Interleukin-17 (IL-17) is critical for recruiting neutrophils and controlling dermatophyte infection. |
Tumor necrosis factor-alpha (TNF-α) promotes inflammation and fungal clearance. | |
Defensins are antimicrobial peptides produced by keratinocytes that inhibit fungal growth. |
Treatments
Pharmacological Treatments
Terbinafine
- Mechanism:
Inhibits squalene epoxidase, disrupting fungal cell membrane synthesis.
- Side effects:
Gastrointestinal upset
Rash
Elevated liver enzymes
- Clinical role:
First-line
Itraconazole
- Mechanism:
Inhibits fungal lanosterol 14α-demethylase, impairing ergosterol synthesis.
- Side effects:
Hepatotoxicity
Heart failure exacerbation
Drug interactions
- Clinical role:
Second-line
Griseofulvin
- Mechanism:
Disrupts fungal mitotic spindle by binding to microtubules, inhibiting cell division.
- Side effects:
Photosensitivity
Headache
Hepatotoxicity
- Clinical role:
Second-line
Topical azoles (e.g., clotrimazole, miconazole)
- Mechanism:
Inhibit fungal lanosterol 14α-demethylase, disrupting ergosterol synthesis locally.
- Side effects:
Local irritation
Contact dermatitis
- Clinical role:
First-line
Topical allylamines (e.g., terbinafine cream)
- Mechanism:
Inhibit squalene epoxidase locally, causing fungal cell membrane disruption.
- Side effects:
Local irritation
Pruritus
- Clinical role:
First-line
Non-pharmacological Treatments
Keep affected skin clean and dry to reduce fungal growth.
Avoid sharing personal items such as towels and clothing to prevent transmission.
Wear breathable, loose-fitting clothing to minimize moisture retention.
Regularly disinfect footwear and socks to reduce fungal reservoirs.
Prevention
Pharmacological Prevention
Topical antifungals such as terbinafine or clotrimazole applied to at-risk skin prevent recurrence.
Oral antifungal prophylaxis may be used in immunocompromised patients with recurrent infections.
Antifungal powders or sprays reduce moisture and fungal colonization in interdigital spaces.
Non-pharmacological Prevention
Maintaining dry, clean skin and avoiding occlusive footwear reduce fungal growth.
Avoiding sharing personal items like towels and shoes prevents transmission.
Wearing breathable clothing and changing socks frequently decreases moisture retention.
Regular foot hygiene and drying between toes prevent tinea pedis.
Screening and treating household contacts reduce reinfection risk.
Outcome & Complications
Complications
Secondary bacterial cellulitis can develop from skin barrier disruption.
Chronic dermatophytosis may cause persistent inflammation and lichenification.
Allergic reactions such as dermatophytid (id) reactions can occur distant from primary lesions.
Scarring alopecia may result from severe tinea capitis.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Tinea (Dermatophytosis - Trichophyton, Microsporum, Epidermophyton spp.) versus Psoriasis
Tinea (Dermatophytosis - Trichophyton, Microsporum, Epidermophyton spp.) | Psoriasis |
|---|---|
Annular, scaly plaques with central clearing and advancing border | Well-demarcated, thick, silvery-white scaly plaques |
Hairline, groin, feet, and other keratinized skin areas | Extensor surfaces, scalp, and nails |
Usually absent or minimal nail changes | Pitting, onycholysis, and oil spots |
Requires antifungal agents for resolution | Improves with topical corticosteroids and vitamin D analogs |
Tinea (Dermatophytosis - Trichophyton, Microsporum, Epidermophyton spp.) versus Seborrheic dermatitis
Tinea (Dermatophytosis - Trichophyton, Microsporum, Epidermophyton spp.) | Seborrheic dermatitis |
|---|---|
Dry, white or gray scales with sharply demarcated edges | Greasy, yellowish scales on erythematous base |
Feet, groin, and other keratinized skin areas | Scalp, nasolabial folds, eyebrows, and chest |
Caused by dermatophyte fungi of Trichophyton, Microsporum, or Epidermophyton | Associated with Malassezia yeast overgrowth |
Requires systemic or topical antifungals targeting dermatophytes | Responds to antifungal shampoos and mild corticosteroids |
Tinea (Dermatophytosis - Trichophyton, Microsporum, Epidermophyton spp.) versus Pityriasis rosea
Tinea (Dermatophytosis - Trichophyton, Microsporum, Epidermophyton spp.) | Pityriasis rosea |
|---|---|
Annular plaques with active, scaly borders and central clearing | Herald patch followed by Christmas-tree distribution of oval plaques |
Chronic or recurrent without spontaneous resolution | Self-limited, resolving within 6-8 weeks |
Fungal infection by dermatophytes | Likely viral (HHV-6/7) etiology |
Requires antifungal therapy for cure | Symptomatic treatment only, no antifungals needed |
Tinea (Dermatophytosis - Trichophyton, Microsporum, Epidermophyton spp.) versus Nummular eczema
Tinea (Dermatophytosis - Trichophyton, Microsporum, Epidermophyton spp.) | Nummular eczema |
|---|---|
Annular plaques with raised scaly borders and central clearing | Coin-shaped, eczematous plaques with oozing and crusting |
Pruritus variable but often present | Severe itching common |
Fungal hyphae visible on KOH prep or biopsy | Spongiosis and epidermal hyperplasia without fungal elements |
Requires antifungal agents for resolution | Improves with topical corticosteroids and emollients |
Tinea (Dermatophytosis - Trichophyton, Microsporum, Epidermophyton spp.) versus Candidiasis
Tinea (Dermatophytosis - Trichophyton, Microsporum, Epidermophyton spp.) | Candidiasis |
|---|---|
Annular plaques with sharply demarcated scaly borders | Erythematous plaques with satellite pustules |
Keratinized skin areas like feet, groin, scalp | Intertriginous areas, mucous membranes |
Septate hyphae and arthroconidia of dermatophytes | Yeast and pseudohyphae of Candida albicans |
Responds to antifungals targeting dermatophytes (terbinafine, griseofulvin) | Responds to antifungals targeting yeasts (azoles, nystatin) |